Document Detail


De-stiffening drug therapy and blood pressure control.
MedLine Citation:
PMID:  21949616     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
In hypertensive subjects, cardiovascular risk reduction is critically related to the decrease of systolic blood pressure (SBP). De-stiffening therapy means that, in a controlled therapeutic trial of long duration, a selective reduction of SBP has been obtained in the studied group by comparison with the control group, and that this SBP reduction is due to a decrease of either arterial stiffness, or wave reflections, or both. Central SBP reduction and cardiovascular remodeling are specifically involved. Most protocols require the presence of an angiotensin II blocker, potentially associated with a diuretic compound and/or a calcium-channel blocker. Cardiovascular outcomes are significantly reduced by comparison with the control group, particularly when this latter group involves administration of a beta-blocking agent.
Authors:
Michel E Safar
Related Documents :
18199346 - Cavernous body reduction in four patients with erectile dysfunction due to insufficient...
4704496 - Direct arterial pressure and electrocardiogram during motor car driving.
11164736 - Sustained reduction of portal pressure by administration of octreotide-lar in portal hy...
15878216 - Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepa...
10459786 - Older subjects show no age-related decrease in cardiac baroreceptor sensitivity.
3718646 - Epidemiology and management of severe symptomatic neonatal hypertension.
Publication Detail:
Type:  Journal Article     Date:  2010-01-29
Journal Detail:
Title:  Integrated blood pressure control     Volume:  3     ISSN:  1178-7104     ISO Abbreviation:  Integr Blood Press Control     Publication Date:  2010  
Date Detail:
Created Date:  2011-09-28     Completed Date:  2011-11-10     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  101562709     Medline TA:  Integr Blood Press Control     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  1-9     Citation Subset:  -    
Affiliation:
Paris-Descartes University, Faculty of Medicine, Hôtel-Dieu Hospital, AP-HP, Diagnosis Center, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Current concepts in combination therapy for the treatment of hypertension: combined calcium channel ...
Next Document:  Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapa...